Authors:
ZACHARSKI LR
ORNSTEIN DL
MEMOLI VA
ROUSSEAU SM
KISIEL W
Citation: Lr. Zacharski et al., EXPRESSION OF THE FACTOR-VII ACTIVATING PROTEASE, HEPSIN, IN-SITU IN RENAL-CELL CARCINOMA, Thrombosis and haemostasis, 79(4), 1998, pp. 876-877
Citation: Dl. Ornstein et Lr. Zacharski, COENZYME-A REDUCTASE INHIBITORS AND STROKE - IN RESPONSE, Annals of internal medicine, 129(2), 1998, pp. 161-162
Citation: Dl. Ornstein et Lr. Zacharki, INHIBITION OF UROKINASE PLASMINOGEN-ACTIVATOR EXPRESSION BY DEFEROXAMINE IN CULTURED HUMAN PROSTATE-CANCER CELLS, Thrombosis and haemostasis, 1997, pp. 2263-2263
Authors:
COHN KH
ORNSTEIN DL
WANG FS
LAPAIX FD
PHIPPS K
EDELSBERG C
ZUNA R
MOTT LA
DUNN JL
Citation: Kh. Cohn et al., THE SIGNIFICANCE OF ALLELIC DELETIONS AND ANEUPLOIDY IN COLORECTAL-CARCINOMA - RESULTS OF A 5-YEAR FOLLOW-UP-STUDY, Cancer, 79(2), 1997, pp. 233-244
Authors:
ORNSTEIN DL
ZACHARSKI LR
MANNING HL
MALONE MG
ROBERT DM
BELLONI DR
NOLL WW
Citation: Dl. Ornstein et al., THROMBOTIC PULMONARY-HYPERTENSION IN A PATIENT WITH HEREDITARY PYRUVATE-KINASE DEFICIENCY WHO IS DOUBLY HETEROZYGOUS FOR PROTEIN-S DEFICIENCY AND PROTHROMBIN 20210-(G-]A) MUTATION, Blood, 90(10), 1997, pp. 3252-3252
Citation: Dl. Ornstein et Lr. Zacharski, DEFEROXAMINE DECREASES STEADY-STATE LEVELS OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR MESSENGER-RNA AND PROTEIN IN CULTURED HUMAN PROSTATE-CANCER CELL-LINE, PC-3, Blood, 88(10), 1996, pp. 3003-3003
Authors:
ZACHARSKI LR
MEMOLI VA
ORNSTEIN DL
ROUSSEAU SM
KISIEL W
KUDRYK BJ
Citation: Lr. Zacharski et al., TUMOR-CELL PROCOAGULANT AND UROKINASE EXPRESSION IN CARCINOMA OF THE OVARY, Journal of the National Cancer Institute, 85(15), 1993, pp. 1225-1230